Antitumor effects of telomerase-specific replication-selective oncolytic viruses for adenoid cystic carcinoma cell lines

Daisuke Sato, Yuji Kurihara, Seiji Kondo, Tatsuo Shirota, Yasuo Urata, Toshiyoshi Fujiwara, Satoru Shintani

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We evaluated the antitumor effect of a telomerase-specific replication-selective adenovirus (Telomelysin, OBP-301) for adenoid cystic carcinoma (ACC) in vitro and in vivo. Adenovirus E1 gene expression was controlled by human telomerase reverse transcription (hTERT). Infection of ACC cells by OBP-301 induced high E1A mRNA expression and subsequent oncolytic cell death in a dose-dependent manner. Using OBP-401 (TelomeScan), a genetically engineered adenovirus that carries the GFP gene under the control of the cytomegalovirus (CMV) promoter at the deleted E3 region of OBP-301, ACC cells expressed bright GFP fluorescence as early as 12 h after OBP-401 infection. The fluorescence intensity gradually increased in a time-dependent manner, followed by rapid cell death due to the cytopathic effect of OBP-401, as evidenced by the floating, highly light-refractive cells using phase-contrast microscopy. Effects of intratumorally injected OBP-401 against established Acc2 xenograft tumors were seen in BALB/c nu/nu mice. The levels of GFP expression following ex vivo infection of OBP-401 may be of value as a positive predictive marker for the outcome of telomerase-specific virotherapy. Our data clearly indicated that telomerase-specific oncolytic adenoviruses have significant therapeutic potential against human ACC in vitro and in vivo. These results suggest that treatment with OBP-301 and OBP-401 may improve the quality of life of oral cancer patients.

Original languageEnglish
Pages (from-to)2659-2664
Number of pages6
JournalOncology Reports
Volume30
Issue number6
DOIs
Publication statusPublished - Dec 2013

Fingerprint

Oncolytic Viruses
Adenoid Cystic Carcinoma
Telomerase
Adenoviridae
Cell Line
Cell Death
Infection
Fluorescence
Phase-Contrast Microscopy
Mouth Neoplasms
Cytomegalovirus
Heterografts
Reverse Transcription
Quality of Life
Gene Expression
Light
Messenger RNA
Therapeutics
Genes
Neoplasms

Keywords

  • Adenoid cystic carcinoma
  • Antitumor
  • Telomerase
  • Telomerase-specific replication-selective oncolytic viruses

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Antitumor effects of telomerase-specific replication-selective oncolytic viruses for adenoid cystic carcinoma cell lines. / Sato, Daisuke; Kurihara, Yuji; Kondo, Seiji; Shirota, Tatsuo; Urata, Yasuo; Fujiwara, Toshiyoshi; Shintani, Satoru.

In: Oncology Reports, Vol. 30, No. 6, 12.2013, p. 2659-2664.

Research output: Contribution to journalArticle

Sato, Daisuke ; Kurihara, Yuji ; Kondo, Seiji ; Shirota, Tatsuo ; Urata, Yasuo ; Fujiwara, Toshiyoshi ; Shintani, Satoru. / Antitumor effects of telomerase-specific replication-selective oncolytic viruses for adenoid cystic carcinoma cell lines. In: Oncology Reports. 2013 ; Vol. 30, No. 6. pp. 2659-2664.
@article{59199781e3f840ad8c939d9335de01c8,
title = "Antitumor effects of telomerase-specific replication-selective oncolytic viruses for adenoid cystic carcinoma cell lines",
abstract = "We evaluated the antitumor effect of a telomerase-specific replication-selective adenovirus (Telomelysin, OBP-301) for adenoid cystic carcinoma (ACC) in vitro and in vivo. Adenovirus E1 gene expression was controlled by human telomerase reverse transcription (hTERT). Infection of ACC cells by OBP-301 induced high E1A mRNA expression and subsequent oncolytic cell death in a dose-dependent manner. Using OBP-401 (TelomeScan), a genetically engineered adenovirus that carries the GFP gene under the control of the cytomegalovirus (CMV) promoter at the deleted E3 region of OBP-301, ACC cells expressed bright GFP fluorescence as early as 12 h after OBP-401 infection. The fluorescence intensity gradually increased in a time-dependent manner, followed by rapid cell death due to the cytopathic effect of OBP-401, as evidenced by the floating, highly light-refractive cells using phase-contrast microscopy. Effects of intratumorally injected OBP-401 against established Acc2 xenograft tumors were seen in BALB/c nu/nu mice. The levels of GFP expression following ex vivo infection of OBP-401 may be of value as a positive predictive marker for the outcome of telomerase-specific virotherapy. Our data clearly indicated that telomerase-specific oncolytic adenoviruses have significant therapeutic potential against human ACC in vitro and in vivo. These results suggest that treatment with OBP-301 and OBP-401 may improve the quality of life of oral cancer patients.",
keywords = "Adenoid cystic carcinoma, Antitumor, Telomerase, Telomerase-specific replication-selective oncolytic viruses",
author = "Daisuke Sato and Yuji Kurihara and Seiji Kondo and Tatsuo Shirota and Yasuo Urata and Toshiyoshi Fujiwara and Satoru Shintani",
year = "2013",
month = "12",
doi = "10.3892/or.2013.2738",
language = "English",
volume = "30",
pages = "2659--2664",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "6",

}

TY - JOUR

T1 - Antitumor effects of telomerase-specific replication-selective oncolytic viruses for adenoid cystic carcinoma cell lines

AU - Sato, Daisuke

AU - Kurihara, Yuji

AU - Kondo, Seiji

AU - Shirota, Tatsuo

AU - Urata, Yasuo

AU - Fujiwara, Toshiyoshi

AU - Shintani, Satoru

PY - 2013/12

Y1 - 2013/12

N2 - We evaluated the antitumor effect of a telomerase-specific replication-selective adenovirus (Telomelysin, OBP-301) for adenoid cystic carcinoma (ACC) in vitro and in vivo. Adenovirus E1 gene expression was controlled by human telomerase reverse transcription (hTERT). Infection of ACC cells by OBP-301 induced high E1A mRNA expression and subsequent oncolytic cell death in a dose-dependent manner. Using OBP-401 (TelomeScan), a genetically engineered adenovirus that carries the GFP gene under the control of the cytomegalovirus (CMV) promoter at the deleted E3 region of OBP-301, ACC cells expressed bright GFP fluorescence as early as 12 h after OBP-401 infection. The fluorescence intensity gradually increased in a time-dependent manner, followed by rapid cell death due to the cytopathic effect of OBP-401, as evidenced by the floating, highly light-refractive cells using phase-contrast microscopy. Effects of intratumorally injected OBP-401 against established Acc2 xenograft tumors were seen in BALB/c nu/nu mice. The levels of GFP expression following ex vivo infection of OBP-401 may be of value as a positive predictive marker for the outcome of telomerase-specific virotherapy. Our data clearly indicated that telomerase-specific oncolytic adenoviruses have significant therapeutic potential against human ACC in vitro and in vivo. These results suggest that treatment with OBP-301 and OBP-401 may improve the quality of life of oral cancer patients.

AB - We evaluated the antitumor effect of a telomerase-specific replication-selective adenovirus (Telomelysin, OBP-301) for adenoid cystic carcinoma (ACC) in vitro and in vivo. Adenovirus E1 gene expression was controlled by human telomerase reverse transcription (hTERT). Infection of ACC cells by OBP-301 induced high E1A mRNA expression and subsequent oncolytic cell death in a dose-dependent manner. Using OBP-401 (TelomeScan), a genetically engineered adenovirus that carries the GFP gene under the control of the cytomegalovirus (CMV) promoter at the deleted E3 region of OBP-301, ACC cells expressed bright GFP fluorescence as early as 12 h after OBP-401 infection. The fluorescence intensity gradually increased in a time-dependent manner, followed by rapid cell death due to the cytopathic effect of OBP-401, as evidenced by the floating, highly light-refractive cells using phase-contrast microscopy. Effects of intratumorally injected OBP-401 against established Acc2 xenograft tumors were seen in BALB/c nu/nu mice. The levels of GFP expression following ex vivo infection of OBP-401 may be of value as a positive predictive marker for the outcome of telomerase-specific virotherapy. Our data clearly indicated that telomerase-specific oncolytic adenoviruses have significant therapeutic potential against human ACC in vitro and in vivo. These results suggest that treatment with OBP-301 and OBP-401 may improve the quality of life of oral cancer patients.

KW - Adenoid cystic carcinoma

KW - Antitumor

KW - Telomerase

KW - Telomerase-specific replication-selective oncolytic viruses

UR - http://www.scopus.com/inward/record.url?scp=84892422554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892422554&partnerID=8YFLogxK

U2 - 10.3892/or.2013.2738

DO - 10.3892/or.2013.2738

M3 - Article

VL - 30

SP - 2659

EP - 2664

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 6

ER -